CD Protein Inhibitors Immune Checkpoint Inhibitors Immunotherapy Tyrosine Kinase Inhibitors Cytokine Serine-Threonine Kinase Inhibitors | Gastric Cancer | Gastroesophageal Junction Adenocarcinoma | Esophageal Adenocarcinoma | Lung Non-Squamous Non-Small Cell Cancer | Biliary Tract Cancer | Esophageal Cancer | Gastric Adenocarcinoma |
---|---|---|---|---|---|---|---|
pembrolizumab | |||||||
bevacizumab + SHR-1701 | |||||||
nivolumab |